monoclonal gammopathy undetermined significance smoldering multiple myeloma curcumin randomized double-blind placebo-controlled cross pubmed ncbi abstract monoclonal gammopathy undetermined significance mgus smoldering multiple myeloma smm represent models studying multiple myeloma precursor disease developing early intervention strategies administering num dose curcumin performed randomised double-blind placebo-controlled cross-over study open-label extension study num dose assess effect curcumin flc response bone turnover patients mgus smm num patients num mgus num smm randomised groups received num curcumin num placebo crossing num months completion num arm patients option entering open-label num dose extension study blood urine samples collected intervals specific marker analyses group values expressed num sd data time intervals groups compared student's paired t-test num patients completed num cross-over study num num extension study curcumin therapy decreased free light-chain ratio rflc reduced difference clonal nonclonal light-chain dflc involved free light-chain iflc udpyd marker bone resorption decreased curcumin arm increased placebo arm serum creatinine levels tended diminish curcumin therapy findings suggest curcumin potential slow disease process patients mgus smm copyright num wiley periodicals 
